Pay in 4 interest-free payments of $5.66 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Accessed April 27, 2026
For most Aetna members in 2026, starting with Wegovy is the practical first step
Treatment for kidney disease The positive results from FLOW demonstrate[d] the potential for semaglutide to become the first GLP-1 treatment option for people living with type 2 diabetes and chronic kidney disease, Lange said at the time study results were released
doi: 10.1186/s12916-015-0310-y 60 GardnerABolesR
US$ 22.64
US$ 27.78
US$ 20.18
US$ 26.86
US$ 23.70
US$ 24.29
US$ 27.42
US$ 24.06
US$ 26.04
US$ 25.61
US$ 24.80
US$ 28.33
US$ 20.93
US$ 23.87
US$ 21.29
US$ 24.37
